Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

MORGANTOWN, W.Va (WDTV) - The Morgantown Farmers Market is expanding. This is the first time they are doing the summer market on Wednesdays. Folks who loved local produce, bread, and other items came ...

Mylan NV finalized a $465 million settlement with the U.S. Justice Department. The settlement resolves claims the pharmaceutical company overcharged the government for its EpiPen emergency allergy ...

Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its more "consumer-friendly ...

One company makes Xanax and Viagra. The other makes the popular EpiPen drug for people with allergies. Now they may be close to merging. The Wall Street Journal reported Saturday that pharma giants ...

Comprehensive report includes a look at Mylan's historical impact on patients, employees, the environment, global public health and the community HERTFORDSHIRE, England and PITTSBURGH, May 4, 2020 ...

Mylan, a company best known for generic drugs, watched its stock slide last year after it was named along with other generic-drug manufacturers in a case alleging price-fixing. The lawsuit, brought by ...

Get all latest & breaking news on Mylan Inc. Watch videos, top stories and articles on Mylan Inc at moneycontrol.com.

Last year, furor over the skyrocketing price of Mylan’s life-saving EpiPens hit a fever pitch. Lawmakers seethed, parents broke into tears at pharmacy counters, regulators opened investigations, ...

Mylan, part of Viatris, exits Biocon by selling its 5.64% stake for ₹3,679 crore. Domestic mutual funds and global investors buy shares as Biocon gains over 6%.